Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
Dr.Reddy’s has entered into a definitive agreement toacquire a portfolio of 42 approved, non-marketed Abbreviated New DrugApplications (ANDAs) in the U.S.
MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…
India’s Dr. Reddy’s has re-launched its Esomeprazole Magnesium Delayed-Release Capsules, which is a therapeutic equivalent generic version of Nexium Delayed-Release…
Dr. Reddy’s Laboratories has issued a press release reacting to certain statements that appeared in the certain media on Thursday.